日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Potent Triazolopyridine Myeloperoxidase Inhibitors

强效三唑并吡啶类髓过氧化物酶抑制剂

Wurtz, Nicholas R; Viet, Andrew; Shaw, Scott A; Dilger, Andrew; Valente, Meriah N; Khan, Javed A; Jusuf, Sutjano; Narayanan, Rangaraj; Fernando, Gayani; Lo, Fred; Liu, Xiaoqin; Locke, Gregory A; Kopcho, Lisa; Abell, Lynn M; Sleph, Paul; Basso, Michael; Zhao, Lei; Wexler, Ruth R; Duclos, Franck; Kick, Ellen K

PK/PD Disconnect Observed with a Reversible Endothelial Lipase Inhibitor

使用可逆性内皮脂肪酶抑制剂观察到PK/PD脱节

Hangeland, Jon J; Abell, Lynn M; Adam, Leonard P; Jiang, Ji; Friends, Todd J; Haque, Lauren E; Neels, James; Onorato, Joelle M; Chen, Alice Ye A; Taylor, David S; Yin, Xiaohong; Harrity, Thomas W; Basso, Michael D; Yang, Richard; Sleph, Paul G; Gordon, David A; Huang, Christine S; Wexler, Ruth R; Finlay, Heather J; Lawrence, R Michael

Triazolopyrimidines identified as reversible myeloperoxidase inhibitors

三唑并嘧啶类化合物被鉴定为可逆性髓过氧化物酶抑制剂

Duclos, Franck; Abell, Lynn M; Harden, David G; Pike, Kristen; Nowak, Kimberly; Locke, Gregory A; Duke, Gerald J; Liu, Xiaoqin; Fernando, Gayani; Shaw, Scott A; Vokits, Benjamin P; Wurtz, Nicholas R; Viet, Andrew; Valente, Meriah N; Stachura, Sylwia; Sleph, Paul; Khan, Javed A; Gao, Ji; Dongre, Ashok R; Zhao, Lei; Wexler, Ruth R; Gordon, David A; Kick, Ellen K